Main > PNEUMOLOGY > DE. B. ILD>Treat>Tirosine Kinase>



DE. B. ILD>Treat>Tirosine Kinase>'s subsections
(*) USA Approval Date: 2020. 03.09
>Inhibitor Capsules
Company
Generic Name: Nintedanib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2021. 04.27
TradeMark
TradeMark Web-Site

DE. B. ILD>Treat>Tirosine Kinase>'s products
This section has no products